BioAlliance Pharma : Quarterly information as of September 30, 2013

15-11-2013 Business Wire HealthComments (0)

BioAlliance PharmaPharmaceutical

Regulatory News : BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, today published the major key milestones achieved during the third quarter of 2013. July was marked by a successful capital increase which enabled the Company to raise a net amount of €8.4 million and showed strong support from its shareholders, specifically the two largest, Financière

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top